Business
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025 Schlieren (Zürich), Switzerland – September 30, 2025 – Kuros Biosciences (“Kuros” or the “Company”), a leader in innovative biologic technologies, today announced the full commercial launch of the MagnetOs™ MIS Delivery System. Purpose-built for Minimally Invasive Surgical (MIS) procedures, the system is designed to meet every surgeon’s need in bone graft delivery. It will be showcased at the Kuros booth and
About this update from Kuros Biosciences Ltd.
[{"type":"image","alt":"Kuros Biosciences AG","displaySize":"","headline":null,"caption":"Kuros Biosciences AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":53,"url":"https://media.zenfs.com/en/globenewswire.com/53e70503ab3216cc1e8d831966241fc5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JKr5n4LkuMlKdEYCBjLkqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/53e70503ab3216cc1e8d831966241fc5","width":300,"height":53}},"lazy":false},{"type":"text","content":"Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025","length":88,"tagName":"p"},{"type":"text","content":"Schlieren (Zürich), Switzerland – September 30, 2025 – Kuros Biosciences (“Kuros” or the “Company”), a leader in innovative biologic technologies, today announced the full commercial launch of the MagnetOs™ MIS Delivery System. Purpose-built for Minimally Invasive Surgical (MIS) procedures, the system is designed to meet every surgeon’s need in bone graft delivery. It will be showcased at the Kuros booth and featured in a podium presentation at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Meeting on October 3, 2025, in Las Vegas, Nevada.MagnetOs MIS sets a new standard in minimally invasive surgery as the only bone graft delivery system that is sterile, prefilled, free of human tissue, and with a mechanism of action backed by Level I clinical evidence.1,2 MagnetOs MIS ensures surgeons no longer need to compromise, meeting all critical needs for minimally invasive bone grafting:","length":911,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Always ready when you are – single-use, sterile, and prefilled, available off the shelf with no refrigeration or thawing required1","length":130,"tagName":"p"}]},{"val":[{"type":"text","content":"Faster efficiency – graft placement three times faster than traditional funnel-based delivery methods3","length":102,"tagName":"p"}]},{"val":[{"type":"text","content":"Engineered for optimal handling – enabling easy, controlled, and precise graft placement in hard-to-reach spaces","length":112,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":344,"olType":false},{"type":"text","content":"Built on the proven science of MagnetOs and its proprietary NeedleGrip™ submicron surface technology ...